Evolus
EOLS
#7666
Rank
S$0.55 B
Marketcap
S$8.41
Share price
-6.86%
Change (1 day)
-5.98%
Change (1 year)

Earnings for Evolus (EOLS)

Earnings in 2026 (TTM): -S$38.97 Million

According to Evolus 's latest financial reports the company's current earnings are S$0.32 Billion. In 2025 the company made an earning of -S$65.75 Million a decrease over its 2024 earnings that were of -S$64.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Evolus from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$38.97 Million-40.73%
2025 -S$65.75 Million2.43%
2024 -S$64.19 Million-19.11%
2023 -S$79.35 Million-17.23%
2022 -S$95.87 Million59.02%
2021 -S$60.29 Million-71.32%
2020 -S$0.22 Billion55.09%
2019 -S$0.14 Billion124.48%
2018 -S$60.38 Million298.96%
2017 -S$15.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-S$0.21 Billion 414.62%๐Ÿ‡บ๐Ÿ‡ธ USA